Pulmonology CME - Disease Areas | Medical Studies, Videos & More

Education

Search

Beyond Pulmonary

Browse over 450 CME/CE courses on FranceFoundation.com

VIEW ALL EDUCATION

Page 3 of 5

Results 151 - 225 of 303

Current Perspective on Antifibrotic Therapy for Patients with IPF

Technology Improving SMA Patients’ Quality of Life

Nusinersen Treatment Outcomes in Later-Onset SMA

Patients with Severe SMA Need Additional Respiratory Management

Clear Expectations Needed in SMA Patient Management

The Changing Landscape of SMA–Updates from Copenhagen, Denmark

Pulmonologists as the Gatekeepers of Precision Medicine

Interstitial Pneumonia with Autoimmune Features (IPAF)

How to Identify & Manage Patients with Progressive-Fibrosing ILD

Acute Exacerbations of IPF

Personalized Medicine for Improving Asthma Care: An Animated Video Series

9815-developments

New Developments in Pulmonary Diseases: Optimizing Patient Outcomes

9815-palliative slides

Palliative Medicine in Pulmonology

Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation

Dyspnea and Disease are Progressing: What to Do?

Thoracic Radiology

A Closer Look at ILD, Sarcoidosis, and CTEPH

New Developments in Pulmonary Diseases: Optimizing Patient Outcomes

Discussions with Patients to Optimize Asthma Control

9916-0004_treatment

Who Should be Targeted For Treatment With Biologic Therapy?

9916-0003_endotypes

Endotypes and Phenotypes in Asthma

Mechanisms of Action of Biologic Therapies for Severe Asthma

Approved Medications for the Treatment of Severe Asthma

9907-0006_shared

Engage Your Patients in Shared Decision-Making

9907-0005_cardio

Is It IPF or Cardiovascular Disease?

Interstitial Pneumonia with Autoimmune Features

9907-0003_pf-ild

How to Identify Progressive Fibrosing ILD

When Is It a Connective Tissue Disease?

9907-0001_guidelines

How to Use IPF Guidelines to Make a Diagnosis

Advanced Care Planning and Palliative Care Models for Patients with IPF

Dyspnea Assessment in Patients with IPF

Which Patients with IPF Should be on Antifibrotics?

The Impact of Anticoagulation Use on IPF Patient Outcomes

Patient-Centered Outcomes for Patients with IPF: Activity Monitoring

Connective Tissue Disease-Related ILD is Now in the Limelight

Biomarkers in IPF and Other ILDs

9840-glassberg2

Evaluation and Diagnosis of IPF

9840-glassberg1

Initial Treatment Decisions of IPF

The Changing Landscape of SMA–Updates from Anaheim, CA

What if President Calvin Coolidge Was Your Asthma Patient?

Optimizing Management of IPF

New_Concepts_in_the_Pathobiology_of_Asthma_264x150

New Concepts in the Pathobiology of Asthma

What are the Most Exciting Things Happening in Pulmonary Disease?

When Is a Cough Not Just a Cough?

Diagnosing ILDs Such as IPF and More

Beyond the Basics: Complex ILD Cases

PowerPoint Slides: Achieving Better Control of Severe Asthma

How Would You Manage President Theodore Roosevelt’s Asthma Today?

New Tools to Improve the Diagnosis of IPF vs Other ILDs

New Research on Therapies for Patients with Pulmonary Fibrosis

The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD

2019 Summer Pulmonary Updates: The Experts Weigh In

U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine

sma-journal-icon_263x0

Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease

Reporting HRCT Findings for ILD from a Multidisciplinary Team

A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story

How Pulmonary Arterial Hypertension Has Changed Iain’s Life

SMA: Data, Insights and Practice

From Bench to Bedside: Gene Therapy Approaches for Rare Diseases

Management of Mycobacterium Abscessus Lung Disease

Difficult to Treat Mycobacterium Avium Complex Lung Disease

Management of Mycobacterium Avium Complex Lung Disease

The Latest from a Recent Pulmonary Conference in San Antonio

Updates in Inoperable CTEPH

The Importance of Early Integration of Palliative Care

Management of IPF Patients in 2018

Updates in the Diagnosis of ILD and the Role of Cryobiopsy

Overview of the Latest Clinical Trials in IPF

Evolution of Antifibrotic Therapy in IPF

Take Home Messages from the 2018 CHEST Annual Meeting

What We’re Learning from the IPF-PRO Registry

Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines

Emerging Treatments for NTM Lung Disease

Nontuberculous Mycobacteria Case 2: Alan

NTM_and_Treatment_Strategies_for_Patients_264x150

NTM and Treatment Strategies for Patients with Cavitary Disease

Page 3 of 5